Homepage
Author:
120/80 Mktg
Posted Date:
April 17, 2026
Parker Institute for Cancer Immunotherapy Network Shapes the Future Of Immunotherapy with Latest Research at AACR Annual Meeting 2026
120/80 Mktg
April 17, 2026
Assort Health Launches First Voice AI Agents for Dermatology, Enabling Over 5% Increase in Appointment Volume and 200% Labor Capacity
120/80 Mktg
April 16, 2026
Parker Institute for Cancer Immunotherapy and Cancer Vaccine Coalition Unite to Accelerate Cancer Prevention and Treatment as Momentum Builds for Cancer Vaccines
120/80 Mktg
April 14, 2026
Charlie Health Names New Chief Technology Officer to Accelerate Technology and AI Strategy
120/80 Mktg
March 30, 2026
Parker Institute for Cancer Immunotherapy Appoints Bolyn Hubby as Chief of Staff to Strengthen Organization Excellence During Period of Growth
120/80 Mktg
March 26, 2026
/C O R R E C T I O N — Bluenote/
120/80 Mktg
March 11, 2026
CMIC Partners with Bluenote to Transform Clinical Development Operations with Agentic AI
120/80 Mktg
March 10, 2026
Parker Institute for Cancer Immunotherapy Announces Appointment of Bob Purcell as Chief Communications Officer
120/80 Mktg
February 25, 2026
Lantern Expands Comprehensive Cancer Solution with Ongoing Clinical Reviews and Continuous Patient Engagement
120/80 Mktg
February 12, 2026
Parker Institute for Cancer Immunotherapy Collaborates with Conquer Cancer and ASCO to Support Promising Cancer Research
120/80 Mktg
January 28, 2026
1
2
Next
